| 2024-02-21 | DiVincenzo Jonathan P. | EVP, Pres, Central Labs & Intl | Sell | 500 | $215.49 | $107,745.05 | -12.8% | → |
| 2024-02-21 | EISENBERG GLENN A | Chief Financial Officer, EVP | Sale+OE | 8,218 | $217.61 | $1,788,303.60 | -14.4% | → |
| 2024-02-13 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sell | 237 | $226.45 | $53,668.65 | -3.0% | → |
| 2024-02-08 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sell | 259 | $222.06 | $57,513.54 | -3.3% | → |
| 2024-02-05 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sale+OE | 193 | $220.57 | $42,570.01 | -2.5% | → |
| 2023-11-16 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sell | 1,384 | $210.71 | $291,626.79 | -39.9% | → |
| 2023-08-08 | ANDERSON KERRII B | Director | Sell | 5,000 | $211.57 | $1,057,832.50 | -24.7% | → |
| 2023-06-29 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sell | 212 | $240.00 | $50,880.00 | -2.7% | → |
| 2023-05-19 | Kirchgraber Paul R | CEO, Covance Drug Development | Sale+OE | 4,300 | $216.91 | $932,706.98 | -24.9% | → |
| 2023-05-18 | Schroeder Mark S | EVP, Pres Diagnostics & COO | Sale+OE | 1,500 | $216.77 | $325,155.00 | -18.3% | → |
| 2023-03-31 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sell | 3,897 | $225.81 | $879,981.57 | -36.8% | → |
| 2023-02-21 | Kirchgraber Paul R | CEO, Covance Drug Development | Sale+OE | 8,000 | $250.58 | $2,004,675.20 | -46.9% | → |
| 2023-02-14 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sell | 309 | $247.63 | $76,517.67 | -4.4% | → |
| 2023-02-07 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sell | 409 | $243.01 | $99,391.09 | -5.8% | → |
| 2023-02-07 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sell | 219 | $243.01 | $53,219.19 | -3.9% | → |
| 2023-02-03 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sale+OE | 173 | $253.90 | $43,924.70 | -3.1% | → |
| 2023-02-03 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sale+OE | 324 | $253.90 | $82,263.60 | -4.6% | → |
| 2022-11-08 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sell | 1,116 | $232.67 | $259,659.72 | -14.3% | → |
| 2022-09-26 | EISENBERG GLENN A | Chief Financial Officer, EVP | Sell | 25,000 | $210.62 | $5,265,576.18 | -14.7% | → |
| 2022-09-07 | Caveney Brian J | EVP, President of Diagnostics | Buy | 44 | $231.20 | $10,250.96 | +0.3% | → |
| 2022-08-03 | EISENBERG GLENN A | Chief Financial Officer, EVP | Sale+OE | 32,100 | $253.94 | $8,151,449.47 | -15.2% | → |
| 2022-08-01 | Wilkinson Peter J | SVP, Chief Accounting Officer | Sale+OE | 2,576 | $258.40 | $665,634.56 | -31.2% | → |
| 2022-06-07 | Caveney Brian J | EVP, President of Diagnostics | Buy | 42 | $242.19 | $10,173.56 | +0.3% | → |
| 2022-03-29 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sell | 2,356 | $277.11 | $652,871.16 | -26.3% | → |
| 2022-03-29 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sell | 2,449 | $277.11 | $678,642.39 | -31.7% | → |
| 2022-03-25 | Williams R Sanders | Director | Sell | 572 | $272.98 | $156,144.56 | -8.2% | → |
| 2022-03-10 | Summy Amy B. | EVP, Chief Marketing Officer | Sell | 249 | $262.21 | $65,290.29 | -49.9% | → |
| 2022-02-16 | NEUPERT PETER M | Director | Buy | 3,500 | $263.66 | $922,815.00 | +14.3% | → |
| 2022-02-15 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sell | 207 | $273.98 | $56,713.86 | -3.0% | → |
| 2022-02-15 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sell | 207 | $273.98 | $56,713.86 | -3.8% | → |
| 2022-02-07 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sale+OE | 204 | $277.38 | $56,585.52 | -3.0% | → |
| 2022-02-07 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sale+OE | 218 | $277.38 | $60,468.84 | -4.0% | → |
| 2022-02-03 | Schroeder Mark S | EVP, President-Diagnostics Lab | Sale+OE | 161 | $271.81 | $43,761.41 | -2.5% | → |
| 2022-02-03 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sale+OE | 172 | $271.81 | $46,751.32 | -3.2% | → |
| 2021-12-15 | Gilliland Dwight Gary | Director | Sell | 500 | $302.26 | $151,127.83 | -1.9% | → |
| 2021-09-15 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sale+OE | 4,500 | $296.78 | $1,335,510.00 | -46.1% | → |
| 2021-06-07 | van der Vaart Sandra D | EVP, Chief Legal Officer | Sale+OE | 4,500 | $266.56 | $1,199,520.00 | -46.2% | → |